Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

TSHA Taysha Gene Therapies Inc

2,18

-0,48 (-18,05%)

26 Juin 2024 - Fermé

Retardé de 15 minutes

Another Biotech Steals The Show Following Major Clinical Data Release

There was some pretty substantial news coming out of Dallas, TX this morning after a biotech company shared initial clinical data from the first pediatric patient from the REVEAL...

To read the full story on AllPennyStocks.com, click here.

Taysha Gene Therapies (NASDAQ:TSHA)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Plus de graphiques de la Bourse Taysha Gene Therapies

Taysha Gene Therapies (NASDAQ:TSHA)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024

Plus de graphiques de la Bourse Taysha Gene Therapies

Actualités Taysha Gene Therapies Inc

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Mercredi 26 Juin 2024 ( il y a 6 heures) • GlobeNewswire Inc.

Form 8-K - Current report
Mardi 18 Juin 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
Mardi 18 Juin 2024 ( il y a 1 semaine) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vendredi 7 Juin 2024 ( il y a 3 semaines) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 31 Mai 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 30 Mai 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 8-K - Current report
Mardi 14 Mai 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mardi 14 Mai 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
Mardi 14 Mai 2024 ( il y a 1 mois) • GlobeNewswire Inc.

Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
Mardi 7 Mai 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vendredi 3 Mai 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
Jeudi 2 Mai 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Plus d'articles sur Taysha Gene Therapies Inc

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales